Activity of Moxifloxacin by Itself and in Combination with Ethambutol, Rifabutin, and Azithromycin In Vitro and In Vivo against Mycobacterium avium

Moxifloxacin activity against Mycobacterium avium complex (MAC) was evaluated in vitro against 25 strains. The MIC was determined to range from 0.125 to 2.0 μg/ml. In addition, U937 macrophage monolayers infected with MAC strain 101 (serovar 1) were treated with moxifloxacin (0.25 to 8 μg/ml) daily,...

詳細記述

書誌詳細

出版年:	Antimicrob Agents Chemother
主要な著者:	Bermudez, Luiz E., Inderlied, Clark B., Kolonoski, Peter, Petrofsky, Mary, Aralar, Priscilla, Wu, Martin, Young, Lowell S.
フォーマット:	Artigo
言語:	Inglês
出版事項:	American Society for Microbiology (ASM) 2001
主題:	Experimental Therapeutics
オンライン･アクセス:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90264/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11120969/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.45.1.217-222.2001
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!